Alivus Life

Hold

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE03Q201024
NSEID: ALIVUS
BSEID: 543322

INR

948.35

6.4 (0.68%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 46.14 k

Click here to access the older version

Cash Flow

Alivus Life Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Compare Cash Flow Results of Alivus Life

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

631.29

2259.57

-1,628.00

-72.06%

Adjustment

79.27

161.91

-82.00

-51.04%

Changes In working Capital

-134.08

-40.95

-94.00

-227.42%

Cash Flow after changes in Working Capital

576.48

2380.53

-1,804.00

-75.78%

Cash Flow from Operating Activities

413.52

1982.97

-1,569.00

-79.15%

Cash Flow from Investing Activities

-116.48

-1919.22

1,803.00

93.93%

Cash Flow from Financing Activities

-279.44

-8.68

-271.00

-3119.35%

Net Cash Inflow / Outflow

17.59

55.07

-38.00

-68.06%

Opening Cash & Cash Equivalents

283.82

134.13

149.00

111.60%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

301.41

189.2

112.00

59.31%

Cash Flow - Snapshot (Standalone) - Mar'24

YoY Growth in year ended Mar 2024 is 35.13% vs -48.79% in Mar 2023

Mar'24

Mar'23

Change(%)

Cash Flow from Operating Activities

413.52

306.01

35.13%